SSRI Pregnancy Exposure Risks Should Be Communicated To Patient – Cmte.

Antidepressant pregnancy exposure risks should be communicated in patient labeling, FDA's Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee recommended June 9